BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 27371886)

  • 1. The gut microbiota and inflammatory bowel diseases.
    Miyoshi J; Chang EB
    Transl Res; 2017 Jan; 179():38-48. PubMed ID: 27371886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IBD and the gut microbiota--from bench to personalized medicine.
    Bellaguarda E; Chang EB
    Curr Gastroenterol Rep; 2015 Apr; 17(4):15. PubMed ID: 25762474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Lee M; Chang EB
    Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota as Therapeutic Targets.
    Xavier RJ
    Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microbial basis of inflammatory bowel diseases.
    Dalal SR; Chang EB
    J Clin Invest; 2014 Oct; 124(10):4190-6. PubMed ID: 25083986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-environment interactions in inflammatory bowel disease pathogenesis.
    Wang MH; Achkar JP
    Curr Opin Gastroenterol; 2015 Jul; 31(4):277-82. PubMed ID: 26039718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
    Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.
    Aleksandrova K; Romero-Mosquera B; Hernandez V
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28867793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between microbes and the immune response in inflammatory bowel disease.
    Goethel A; Croitoru K; Philpott DJ
    J Physiol; 2018 Sep; 596(17):3869-3882. PubMed ID: 29806140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
    Reinisch W
    Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases.
    Sundin J; Öhman L; Simrén M
    Psychosom Med; 2017 Oct; 79(8):857-867. PubMed ID: 28422780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and IBD: causation or correlation?
    Ni J; Wu GD; Albenberg L; Tomov VT
    Nat Rev Gastroenterol Hepatol; 2017 Oct; 14(10):573-584. PubMed ID: 28743984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.